HOME
Company
Science
Media
Investors
Careers
Contact
To be a world-leading biotech company
Fully integrated development of globally innovative therapeutics
Selective & Pan RAS inhibitors of diverse targets and modalities
Targeting crucial unmet medical needs
Project-driven development of next-generation technical platforms
